Increased dopamine peroxidation in postmortem Parkinsonian brain

被引:19
作者
De Iuliis, A
Burlina, AP
Boschetto, R
Zambenedetti, P
Arslan, P
Galzigna, L
机构
[1] Univ Padua, Dept Diagnost, I-35121 Padua, Italy
[2] Univ Padua, Dept Neurol & Psychiat Sci, Padua, Italy
[3] Gen Hosp Este, Div Morbid Anat, Este, Italy
[4] Gen Hosp Dolo, Div Morbid Anat, Dolo, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2002年 / 1573卷 / 01期
关键词
Parkinson's disease; dopaminochrome; dopamine peroxidation; dopamine; midbrain; basal ganglia;
D O I
10.1016/S0304-4165(02)00331-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
We have previously reported the presence, in human midbrain, of an enzymatic activity which catalyzes the formation of dopaminochrome from dopamine (DA) and hydrogen peroxide. Here, we report, for the first time, an increased DA peroxidizing activity in the midbrain and basal ganglia of autoptic Parkinsonian brains. The crude activity was determined spectrophotometrically in extracts of paraffin-embedded slices obtained from autopsied brain. No addition of substrate was necessary since endogenous substrates such as DA and hydrogen peroxide were present in the samples. In Parkinson's patients' midbrain, this activity was substantially increased compared to normal midbrain. Moreover, the DA peroxidizing activity, which was absent in basal ganglia of normal people, was detectable in all our Parkinson's patients. These observations suggest that a peroxidizing pathway of DA may be present in human brain. The increased peroxidizing activity in Parkinson's patients generates the toxic compound dopaminochrome which may play a role in the pathogenesis of this disease. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:63 / 67
页数:5
相关论文
共 28 条
[1]
EPR investigations of the iron domain in neuromelanin [J].
Aime, S ;
Bergamasco, B ;
Biglino, D ;
Digilio, G ;
Fasano, M ;
Giamello, E ;
Lopiano, L .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1361 (01) :49-58
[2]
BRAIN PEROXIDASE AND CATALASE IN PARKINSON DISEASE [J].
AMBANI, LM ;
VANWOERT, MH ;
MURPHY, S .
ARCHIVES OF NEUROLOGY, 1975, 32 (02) :114-118
[3]
Brain iron pathways and their relevance to Parkinson's disease [J].
Berg, D ;
Gerlach, M ;
Youdim, MBH ;
Double, KL ;
Zecca, L ;
Riederer, P ;
Becker, G .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (02) :225-236
[4]
TOXICITY OF AMINOCHROMES [J].
BINDOLI, A ;
RIGOBELLO, MP ;
GALZIGNA, L .
TOXICOLOGY LETTERS, 1989, 48 (01) :3-20
[5]
The structure of neuromelanin and its iron binding site studied by infrared spectroscopy [J].
Bridelli, MG ;
Tampellini, D ;
Zecca, L .
FEBS LETTERS, 1999, 457 (01) :18-22
[6]
Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins [J].
Double, KL ;
Zecca, L ;
Costi, P ;
Mauer, M ;
Griesinger, C ;
Ito, S ;
Ben-Shachar, D ;
Bringmann, G ;
Fariello, RG ;
Riederer, P ;
Gerlach, M .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) :2583-2589
[7]
DUCKWORTH HW, 1970, J BIOL CHEM, V245, P1613
[8]
A rat brain fraction and different purified peroxidases catalyzing the formation of dopaminochrome from dopamine [J].
Galzigna, L ;
Schiappelli, MP ;
Rigo, A ;
Scarpa, M .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1427 (03) :329-336
[9]
Enzymatic dopamine peroxidation in substantia nigra of human brain [J].
Galzigna, L ;
De Iuliis, A ;
Zanatta, L .
CLINICA CHIMICA ACTA, 2000, 300 (1-2) :131-138
[10]
A peroxidase-catalyzed sulfoxidation of promethazine [J].
Galzigna, L ;
Schiappelli, MP ;
Scarpa, M ;
Rigo, A .
FREE RADICAL RESEARCH, 1997, 27 (05) :501-504